Does Platelet Inhibition Predict Surgery Related Bleeding in Patients Undergoing Non-Cardiac Surgery During Dual Antiplatelet Therapy

Medical University of Graz1 site in 1 country207 target enrollmentSeptember 2010

ConditionsPostoperative Bleeding

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Postoperative Bleeding
Sponsor: Medical University of Graz
Enrollment: 207
Locations: 1
Primary Endpoint: increased risk of bleeding (according to TIMI definition)
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing non-cardiac surgery during dual antiplatelet therapy.

Registry

clinicaltrials.gov

Start Date

September 2010

End Date

January 2014

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Medical University of Graz

Responsible Party

Principal Investigator

Helfried Metzler, MD

Prof.

Medical University of Graz

Eligibility Criteria

Inclusion Criteria

•intake of Clopidogrel, Prasugrel, or Ticagrelor within the last 7 days
•spontaneous bleeding or impeding surgery (major vascular surgery, intraperitoneal or intrathoracic surgery, ENT-surgery, orthopedic or trauma surgery, prostatic surgery)